Drug intelligence / Profile preview

boldione

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Boldione is a synthetic anabolic androgenic steroid (AAS) and a direct precursor (prohormone) to the anabolic steroid boldenone. Chemically known as androsta-1,4-diene-3,17-dione or androstadienedione, it features double bonds at positions 1 and 4 of the steroid nucleus with keto groups at positions 3 and 17. Boldione is used industrially as a precursor for various steroid hormones in the estrane and androstane classes[1][2][6]. In humans or animals it can be metabolized into boldenone after administration[6][7]. It has been advertised for its anabolic/androgenic effects such as promoting muscularity and enhancing strength[7], but there are no approved medical indications for its use in humans[2]. Boldione acts primarily by serving as a prohormone to boldenone; both compounds exert their effects through activation of the androgen receptor leading to increased protein synthesis and muscle growth[8]. The drug is banned by sports authorities including WADA due to its performance-enhancing potential[1].

Brand names
Boldione
Other names
androstadienedione1-dehydroandrostenedione1,4-androstadiene-3,17-dioneandrosta-1,4-diene-3,17-dione
02

Targets

AR (Adrenergic receptors)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on boldione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on boldione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call